Quantcast
Last updated on April 21, 2014 at 7:52 EDT

Latest Hepatitis C virus Stories

2012-04-19 06:27:00

ABBOTT PARK, Ill. and WATERTOWN, Mass., April 19, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) and Enanta Pharmaceuticals announced complete data from the study known as "Pilot" - Abbott's initial interferon-free study of its direct-acting antiviral agents for the treatment of hepatitis C (HCV) - showing that 91 percent of genotype 1 infected, treatment-naive patients taking ABT-450/r and ABT-072 combined with ribavirin administered for 12 weeks, achieved sustained viral response at 24 weeks...

2012-04-04 06:24:03

HUDDINGE, Sweden, April 4, 2012 /PRNewswire/ -- - Including an Oral Presentation of final analysis of the TMC435 phase IIb ASPIRE (C206) study that have been selected to be highlighted during the official EASL Press Office activities Medivir AB (OMX: MVIR), a research-based specialty pharmaceutical company focused on infectious diseases, today announces that four abstracts related to its once daily (QD), oral investigational hepatitis C drug TMC435, development in...

2012-03-26 10:24:00

Province to reimburse new chronic hepatitis C treatment MONTREAL, March 26, 2012 /PRNewswire/ - BC PharmaCare recently announced the reimbursement of VICTRELIS(TM) (boceprevir) for eligible British Columbians living with chronic hepatitis C. Boceprevir is a first-in-class oral hepatitis C virus (HCV) protease inhibitor for the treatment of chronic hepatitis C genotype 1 infection. It is to be used in combination with peginterferon alpha and ribavirin (peg/riba) in adult patients...

2012-03-19 19:32:41

Finding Could Pave Way for Drugs Against Virus That Kills More In US Than HIV Chemists at the University of California, San Diego have produced the first high resolution structure of a molecule that when attached to the genetic material of the hepatitis C virus prevents it from reproducing. Hepatitis C is a chronic infectious disease that affects some 170 million people worldwide and causes chronic liver disease and liver cancer. According to the Centers for Disease Control and...

2012-02-21 11:40:16

A towering $60,000 bill, a year of fierce, flu-like symptoms and a running risk of depression are among the possible costs of two new hepatitis C treatments. But according to Stanford University health policy researchers, they might be worth it. Using a computer model of hepatitis C disease – which accounts for different treatments, outcomes, disease stages and genetics – a research team led by Jeremy Goldhaber-Fiebert, PhD, found that new triple-therapies for genotype-1...

2012-02-16 14:41:24

Michael Houghton, who discovered the Hep C strain in 1989, released promising news of a vaccine that shows signs of prevention of all strains of Hep C A University of Alberta researcher and Canada Excellence Research Chair in Virology has made the discovery of a vaccine that will potentially help combat hepatitis C. Michael Houghton, who led the team that discovered the hepatitis C virus in 1989, announced his findings at the Canada Excellence Research Chairs Summit in Vancouver this...

2012-01-31 09:49:38

Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver cancer and cirrhosis. This finding by Dr. Samuel French, an assistant professor of pathology and senior author of the study, builds on previous work by the French laboratory that identified two cellular proteins that are important factors in hepatitis C virus infection. French and his team...

2012-01-25 04:12:52

A molecule embedded in the membrane of human liver cells that aids in cholesterol absorption also allows the entry of hepatitis C virus, the first step in hepatitis C infection, according to research at the University of Illinois at Chicago College of Medicine. The cholesterol receptor offers a promising new target for anti-viral therapy, for which an approved drug may already exist, say the researchers, whose findings were reported online in advance of publication in Nature Medicine....

2012-01-20 08:30:00

CHICAGO, Jan. 20, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Gilead Sciences, Inc. (Nasdaq: GILD), Bristol-Myers Squibb Company (NYSE: BMY), Inhibitex, Inc. (Nasdaq: INHX), Vertex Pharmaceuticals (Nasdaq: VRTX) and Merck (NYSE: MRK). (Logo:...

2012-01-02 23:09:12

Mechanism explains how virus survives in the liver and how a new antiviral works Viral diseases are still one of the biggest challenges to medical science. Thanks to thousands of years of co-evolution with humans, their ability to harness the biology of their human hosts to survive and thrive makes them very difficult to target with medical treatment. Scientists at the University of North Carolina at Chapel Hill, working with colleagues from the University of Colorado, have shown for...


Latest Hepatitis C virus Reference Libraries

11_c18ff18c314281da28f1d18fa4357602
2011-01-20 19:28:48

Hepatitis E virus is an infective organism. The viral particles are 27 to 34 nanometers in diameter. They are non-enveloped and contain a single-strand of positive-sense RNA which is approximately 7300 bases in length. The virus was first visualized in 1983 and molecularly cloned in 1990. Previously it was classified in the family Caliciviridae. Its genome more closely resembles the rubella virus and is now classified as the only member of the genus Hepevirus which has not yet been...

11_9e88d15808b8ecc3fcbbdfcf4ae75786
2011-01-20 19:23:30

Hepatitis C virus (HCV) is an enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. It consists of a core of genetic material surrounded by an icosahedra protective shell of protein. The genome consists of a single open reading frame that is 9600 nucleotide bases long. HCV replication takes several steps. It primarily replicates in the hepatocytes of the liver. It can also reproduce in peripheral blood mononuclear cells. There is a wide variety of genotypes and...

More Articles (2 articles) »